Abstract
Background This study aims to estimate the total number of infected people, evaluate the effects of NPIs on the healthcare system, and predict the expected number of cases, deaths, hospitalizations due to COVID-19 in Turkey.
Methods This study was carried out according to three dimensions. In the first, the actual number of infected people was estimated. In the second, the expected total numbers of infected people, deaths, hospitalizations have been predicted in the case of no intervention. In the third, the distribution of the expected number of infected people and deaths, and ICU and non-ICU bed needs over time has been predicted via a SEIR-based simulator (TURKSAS) in four scenarios.
Results According to the number of deaths, the estimated number of infected people in Turkey on March 21 was 123,030. In the case of no intervention the expected number of infected people is 72,091,595 and deaths is 445,956, the attack rate is 88 · 1%, and the mortality ratio is 0·54%. The ICU bed capacity in Turkey is expected to be exceeded by 4·4-fold and non-ICU bed capacity by 3·21-fold. In the second and third scenarios compliance with NPIs makes a difference of 94,303 expected deaths. In both scenarios, the predicted peak value of occupied ICU and non-ICU beds remains below Turkey’s capacity.
Discussion Predictions show that around 16 million people can be prevented from being infected and 94,000 deaths can be prevented by full compliance with the measures taken. Modelling epidemics and establishing decision support systems is an important requirement.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We declare this study funded by authors.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We used external data from: 1) TurkStat data 2) Turkey Health Statistics
http://tuik.gov.tr/PreIstatistikTablo.do?istab_id=1632
https://www.saglik.gov.tr/TR,62400/saglik-istatistikleri-yilligi-2018-yayinlanmistir.html
